These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 615505)
1. [Comparative study of uric acid concentration in serum and saliva of healthy or hyperuricemic subjects]. Schermann JM; Meunier J; Ricordel I; Masbernard A; Giudicelli C Ann Biol Clin (Paris); 1977; 35(6):467-72. PubMed ID: 615505 [TBL] [Abstract][Full Text] [Related]
2. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study]. Arntz HR; Dreykluft HR; Leonhardt H Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017 [TBL] [Abstract][Full Text] [Related]
3. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia]. Matzkies F; Neuwirth R; Berg G Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920 [TBL] [Abstract][Full Text] [Related]
4. [The effect of benzbromaron in gout patients with limited kidney function]. Kuzmits R; Bresnik W; Müller MM Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087 [TBL] [Abstract][Full Text] [Related]
7. [Normurat (benzbromaron) in the treatment of gout]. Bosmanský K; Trnavský K Z Rheumatol; 1979; 38(9-10):342-8. PubMed ID: 525067 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of urinary calculi by means of a benzbromarone-citrate combination]. Bach D; Hesse A; Strenge A; Vahlensieck W Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of benzbromarone: a new uricosuric drug. Sorensen LB; Levinson DJ Arthritis Rheum; 1976; 19(2):183-90. PubMed ID: 1259799 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients. Hanvivadhanakul P; Akkasilpa S; Deesomchok U J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy and tolerance of a new benzbromarone preparation]. Jelke K; Neubauer M; Krause G; Jüttner A; Angar T; Grosse-Kielisch C; Bach GL Med Welt; 1980 May; 31(21):821-2. PubMed ID: 7392938 [No Abstract] [Full Text] [Related]
12. [Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone]. Matzkies F; Berg G; Minzlaff R Fortschr Med; 1977 Jul; 95(27):1748-50. PubMed ID: 332605 [TBL] [Abstract][Full Text] [Related]
13. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks]. Brzozowska-Jurkowska AM Reumatologia; 1980; 18(3):287-92. PubMed ID: 6999575 [No Abstract] [Full Text] [Related]
14. Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone. Yu TF J Rheumatol; 1976 Sep; 3(3):305-12. PubMed ID: 978666 [TBL] [Abstract][Full Text] [Related]
15. [Effect of benzbromarone in 100mg and 50mg doses on healthy subjects]. Matzkies F; Berg G Fortschr Med; 1977 Jul; 95(27):1745-7. PubMed ID: 903059 [TBL] [Abstract][Full Text] [Related]
17. [Long-term therapy with benzbromarone in uric arthritis]. Bröll H; Sochor H; Tausch G; Eberl R Wien Med Wochenschr; 1975 Sep; 125(28):546-8. PubMed ID: 816095 [No Abstract] [Full Text] [Related]
18. [Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone]. Schräpler P; Schulz E Med Welt; 1976 Mar; 27(12):575-81. PubMed ID: 1263801 [No Abstract] [Full Text] [Related]
19. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites? Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688 [TBL] [Abstract][Full Text] [Related]
20. [Benzbromarone in the treatment of gout]. Kawenoki-Minc E; Brzozowska-Jurkowska AM Reumatologia; 1980; 18(1):61-7. PubMed ID: 6994191 [No Abstract] [Full Text] [Related] [Next] [New Search]